Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2025-12-25 @ 3:08 AM
NCT ID:
NCT03836105
Eligibility Criteria:
Key Inclusion Criteria:
* Eligible for treatment with and prescribed cemiplimab for advanced CSCC or advanced BCC in accordance with approved prescribing information as described in the protocol
Key Exclusion Criteria:
* Receiving cemiplimab for an indication other than advanced CSCC or advanced BCC
* Any condition that, in the opinion of the investigator, may interfere with patient's ability to participate in the study
* Patients concurrently participating in any study including administration of any investigational drug (including cemiplimab) or procedure (including survival follow up)
Note: Other protocol defined Inclusion/Exclusion Criteria apply
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03836105
Study Brief:
Protocol Section:
NCT03836105